Key Topics

Health Care Provision Worldwide

 

Our goal is to empower 100 million women with family planning

We want people to be able to share in medical progress, regardless of their income or background. With this goal in mind, we already collaborate with various partners around the world in programs and initiatives. Our hormonal contraceptives are offered through family planning programs all over the world.

More than 200 million women in low-and-middle income countries still have no access to modern contraceptives. We are committed to providing this there to at least 100 million women between 2020 and 2030. Supporting their family planning also means empowering them to exercise their rights as women and fulfill their potential, which is hugely important for the socioeconomic development of their domestic national economies.

In general, Bayer is working on adapting its pricing policy towards local purchasing power and strengthening the patient access programs to increase the availability and affordability of Bayer products.

We have been actively combating tropical diseases for many years already. For example, we provide two of our active ingredients against African sleeping sickness and Chagas disease, which is prevalent in Latin America, free of charge to the World Health Organization (WHO).

Our goal is to expand access to everyday health for 100 million people in underserved communities around the world

In addition, Bayer will expand access to everyday health for 100 million people in underserved communities around the world. Today, at least half of the world’s population lacks access to essential health services, including self-care. Expanding access to self-care solutions and health education can help patients prevent disease and offer healthcare to communities where self-care might be the only option. With an initial focus on women’s health and expanding access to micronutrients for pregnant women and children, Bayer will increase the availability and affordability of our trusted brands and support self-care initiatives.

Bayer to significantly step-up its sustainability efforts

Prevention of Zika, Malaria, Dengue and Similar Diseases

We also support programs for the control of diseases like malaria, dengue and the Zika virus which are transmitted by disease vectors such as mosquitoes.

Focus Issue Story: Living with Dengue

While dengue fever can affect all population groups and receives widespread attention, other tropical diseases plague the poorest of the poor in our world.

Find out how Bayer fights against neglected tropical diseases.

Our main focus in this regard is on product development and partnership projects. Furthermore, we provide training and educational initiatives aimed at achieving optimum outcomes for public health and the environment that are as sustainable as possible:

We strongly support an integrated management approach

  • Disseminating knowledge: We educate local populations about vector-borne diseases and teach them the skills they need to prevent infections in their specific surroundings.
  • Online learning tools: We have developed an online, interactive learning platform for people living in high-risk areas: the Mosquito Control Learning Lab.
  • Partnerships: Since 2008,we have been working together with the IVCC (International Vector Control Consortium) to develop new insecticides that are urgently needed to protect the health of the population.
  • We also collaborate with national organizations, such as the IMR in Malaysia and the Noguchi Institute in Ghana, and with many other organizations in Africa.
  • Product stewardship: In addition to our range of products, we also provide support and training on the correct use of our products.
  • Collaboration: As part of our collaboration with the U.S. CDC (Center for Disease Control and Prevention) we provide the government in Puerto Rico with products and training materials to support the local population in their efforts to stem the Zika virus.